| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.805 | 0.003 | 0.805 | Bronchodilator | 0.451 0.005 DBMET02847 | ||
| 0.771 | 0.004 | 0.771 | Spasmolytic | 0.56 0.017 DBMET02847 | ||
| 0.733 | 0.002 | 0.733 | Calcium channel L-type activator | 0.614 0.005 DBMET02847 | ||
| 0.701 | 0.001 | 0.701 | Phenylalanine 4-hydroxylase inhibitor | 0.65 0.002 DBMET02847 | ||
| 0.683 | 0.01 | 0.683 | Toll-Like receptor 7 agonist | 0.406 0.057 DBMET02847 | ||
| 0.678 | 0.01 | 0.678 | Toll-Like receptor agonist | 0.4 0.06 DBMET02847 | ||
| 0.654 | 0.015 | 0.654 | Antiobesity | 0.305 0.113 DBMET02847 | ||
| 0.619 | 0.005 | 0.619 | Antiadrenergic | |||
| 0.614 | 0.005 | 0.614 | Adrenaline antagonist | |||
| 0.596 | 0.006 | 0.596 | Psychostimulant | 0.3 0.043 DBMET02847 | ||
| 0.589 | 0.02 | 0.729 | Aldehyde oxidase inhibitor | 0.729 0.006 DBMET02847 | DBMET02847 | |
| 0.589 | 0.029 | 0.661 | Cyclophilin D inhibitor | 0.661 0.018 DBMET02847 | DBMET02847 | |
| 0.571 | 0.019 | 0.571 | Vasodilator, peripheral | 0.553 0.021 DBMET02847 | ||
| 0.549 | 0.006 | 0.713 | Peroxidase inhibitor | 0.713 0.003 DBMET02847 | DBMET02847 | |
| 0.529 | 0.012 | 0.529 | Vasodilator, coronary | 0.387 0.04 DBMET02847 | ||
| 0.521 | 0.004 | 0.521 | Calcium channel activator | 0.448 0.012 DBMET02847 | ||
| 0.512 | 0.013 | 0.512 | Hypoxia-inducible factor 1 alpha inhibitor | 0.337 0.049 DBMET02847 | ||
| 0.532 | 0.04 | 0.532 | Transcription factor NF kappa B inhibitor | 0.431 0.057 DBMET02847 | ||
| 0.498 | 0.028 | 0.498 | 5 Hydroxytryptamine release stimulant | 0.323 0.063 DBMET02847 | ||
| 0.467 | 0.011 | 0.467 | Interleukin agonist | 0.417 0.016 DBMET02847 | ||
| 0.466 | 0.042 | 0.561 | Histamine release inhibitor | 0.561 0.014 DBMET02847 | DBMET02847 | |
| 0.423 | 0.003 | 0.423 | Adrenaline agonist | 0.186 0.008 DBMET02847 | ||
| 0.4 | 0.006 | 0.4 | Anesthetic local | 0.155 0.047 DBMET02847 | ||
| 0.4 | 0.007 | 0.4 | Peptidyltransferase inhibitor | 0.37 0.009 DBMET02847 | ||
| 0.458 | 0.079 | 0.554 | Caspase 9 stimulant | 0.554 0.044 DBMET02847 | DBMET02847 | |
| 0.37 | 0.007 | 0.37 | Acetylcholine M1 receptor antagonist | 0.22 0.034 DBMET02847 | ||
| 0.384 | 0.026 | 0.508 | Vasodilator | 0.508 0.011 DBMET02847 | DBMET02847 | |
| 0.41 | 0.057 | 0.465 | GABA C receptor rho-3 antagonist | 0.465 0.036 DBMET02847 | DBMET02847 | |
| 0.357 | 0.014 | 0.493 | Tyrosine 3 hydroxylase inhibitor | 0.493 0.004 DBMET02847 | DBMET02847 | |
| 0.351 | 0.01 | 0.351 | Cholinergic antagonist | 0.157 0.049 DBMET02847 | ||
| 0.347 | 0.008 | 0.347 | M18 aspartyl aminopeptidase inhibitor | 0.259 0.019 DBMET02847 | ||
| 0.34 | 0.002 | 0.34 | Adenylate cyclase stimulant | 0.262 0.004 DBMET02847 | ||
| 0.338 | 0.002 | 0.338 | Beta 3 adrenoreceptor antagonist | 0.13 0.008 DBMET02847 | ||
| 0.34 | 0.004 | 0.34 | Alpha adrenoreceptor agonist | |||
| 0.407 | 0.074 | 0.579 | 5 Hydroxytryptamine release inhibitor | 0.579 0.014 DBMET02847 | DBMET02847 | |
| 0.341 | 0.011 | 0.341 | Acetylcholine antagonist | 0.15 0.05 DBMET02847 | ||
| 0.383 | 0.053 | 0.626 | Cholesterol antagonist | 0.626 0.015 DBMET02847 | DBMET02847 | |
| 0.329 | 0.007 | 0.329 | Acetylcholine muscarinic antagonist | 0.174 0.032 DBMET02847 | ||
| 0.351 | 0.039 | 0.403 | Sodium/bile acid cotransporter inhibitor | 0.403 0.016 DBMET02847 | DBMET02847 | |
| 0.316 | 0.004 | 0.316 | Acetylcholine M3 receptor antagonist | 0.13 0.013 DBMET02847 | ||
| 0.374 | 0.075 | 0.374 | Calpain 2 inhibitor | 0.229 0.164 DBMET02847 | ||
| 0.308 | 0.01 | 0.322 | Nitric-oxide synthase stimulant | 0.322 0.007 DBMET02847 | DBMET02847 | |
| 0.337 | 0.043 | 0.337 | Cardiotonic | |||
| 0.292 | 0.004 | 0.292 | Toll-Like receptor 3 antagonist | 0.106 0.043 DBMET02847 | ||
| 0.321 | 0.035 | 0.404 | 5 Hydroxytryptamine uptake stimulant | 0.404 0.014 DBMET02847 | DBMET02847 | |
| 0.319 | 0.035 | 0.364 | Cyclic AMP phosphodiesterase inhibitor | 0.364 0.023 DBMET02847 | DBMET02847 | |
| 0.282 | 0.003 | 0.282 | Beta adrenoreceptor antagonist | 0.124 0.009 DBMET02847 | ||
| 0.272 | 0.003 | 0.272 | Beta 2 adrenoreceptor antagonist | 0.098 0.008 DBMET02847 | ||
| 0.284 | 0.02 | 0.372 | Insulin sensitizer | 0.372 0.008 DBMET02847 | DBMET02847 | |
| 0.276 | 0.016 | 0.276 | Adenylate cyclase inhibitor | 0.201 0.025 DBMET02847 | ||
| 0.293 | 0.035 | 0.394 | Anesthetic general | 0.394 0.017 DBMET02847 | DBMET02847 | |
| 0.325 | 0.074 | 0.404 | Antithrombotic | 0.404 0.048 DBMET02847 | DBMET02847 | |
| 0.28 | 0.03 | 0.355 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.355 0.012 DBMET02847 | DBMET02847 | |
| 0.247 | 0.003 | 0.247 | Beta 1 adrenoreceptor antagonist | 0.098 0.01 DBMET02847 | ||
| 0.31 | 0.067 | 0.402 | Interleukin 2 agonist | 0.402 0.027 DBMET02847 | DBMET02847 | |
| 0.296 | 0.053 | 0.376 | Free radical scavenger | 0.376 0.033 DBMET02847 | DBMET02847 | |
| 0.271 | 0.028 | 0.316 | Neurotrophic factor enhancer | 0.316 0.014 DBMET02847 | DBMET02847 | |
| 0.283 | 0.042 | 0.283 | 5 Hydroxytryptamine 1E antagonist | 0.173 0.163 DBMET02847 | ||
| 0.302 | 0.061 | 0.369 | Antioxidant | 0.369 0.041 DBMET02847 | DBMET02847 | |
| 0.236 | 0.002 | 0.236 | Alpha 2a adrenoreceptor agonist | 0.02 0.009 DBMET02847 | ||
| 0.24 | 0.014 | 0.271 | Expectorant | 0.271 0.01 DBMET02847 | DBMET02847 | |
| 0.23 | 0.005 | 0.569 | Glutamate decarboxylase inhibitor | 0.569 0.002 DBMET02847 | DBMET02847 | |
| 0.223 | 0.006 | 0.223 | Sphingomyelinase inhibitor | 0.145 0.027 DBMET02847 | ||
| 0.225 | 0.009 | 0.25 | Mucolytic | 0.25 0.006 DBMET02847 | DBMET02847 | |
| 0.229 | 0.018 | 0.229 | Alpha 2b adrenoreceptor antagonist | |||
| 0.216 | 0.005 | 0.216 | Alpha 1 adrenoreceptor agonist | |||
| 0.215 | 0.01 | 0.215 | Aminoacyl-tRNA synthetase inhibitor | 0.106 0.039 DBMET02847 | ||
| 0.207 | 0.004 | 0.207 | Alpha 2 adrenoreceptor agonist | |||
| 0.198 | 0.003 | 0.198 | Beta adrenoreceptor agonist | 0.07 0.005 DBMET02847 | ||
| 0.262 | 0.067 | 0.456 | Superoxide dismutase inhibitor | 0.456 0.018 DBMET02847 | DBMET02847 | |
| 0.258 | 0.068 | 0.258 | Antiamyloidogenic | 0.172 0.121 DBMET02847 | ||
| 0.346 | 0.156 | 0.346 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.28 0.241 DBMET02847 | ||
| 0.224 | 0.034 | 0.279 | Protein kinase stimulant | 0.279 0.02 DBMET02847 | DBMET02847 | |
| 0.193 | 0.008 | 0.193 | Carbonic anhydrase stimulant | 0.102 0.018 DBMET02847 | ||
| 0.19 | 0.006 | 0.19 | Adrenaline uptake inhibitor | |||
| 0.212 | 0.031 | 0.503 | Alpha-N-acetylglucosaminidase inhibitor | 0.503 0.005 DBMET02847 | DBMET02847 | |
| 0.263 | 0.085 | 0.293 | Insulysin inhibitor | 0.293 0.063 DBMET02847 | DBMET02847 | |
| 0.182 | 0.005 | 0.182 | Acetylcholine M5 receptor antagonist | 0.07 0.031 DBMET02847 | ||
| 0.204 | 0.028 | 0.285 | Cell wall synthesis inhibitor | 0.285 0.011 DBMET02847 | DBMET02847 | |
| 0.176 | 0.002 | 0.176 | Beta 2 adrenoreceptor agonist | 0.09 0.005 DBMET02847 | ||
| 0.214 | 0.043 | 0.214 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.203 | 0.033 | 0.29 | Monophenol monooxygenase inhibitor | 0.29 0.019 DBMET02847 | DBMET02847 | |
| 0.175 | 0.006 | 0.175 | Glutamate (mGluR7) agonist | 0.124 0.027 DBMET02847 | ||
| 0.201 | 0.036 | 0.222 | ATPase inhibitor | 0.222 0.023 DBMET02847 | DBMET02847 | |
| 0.196 | 0.031 | 0.196 | GABA C receptor rho-2 antagonist | 0.173 0.048 DBMET02847 | ||
| 0.193 | 0.028 | 0.193 | Alkylator | 0.151 0.046 DBMET02847 | ||
| 0.19 | 0.028 | 0.19 | Nav1.3 sodium channel blocker | |||
| 0.298 | 0.137 | 0.501 | Antibacterial | 0.501 0.04 DBMET02847 | DBMET02847 | |
| 0.236 | 0.079 | 0.236 | Calpain inhibitor | 0.179 0.136 DBMET02847 | ||
| 0.177 | 0.02 | 0.177 | Protein kinase C gamma inhibitor | 0.112 0.06 DBMET02847 | ||
| 0.198 | 0.042 | 0.371 | Melanin inhibitor | 0.371 0.014 DBMET02847 | DBMET02847 | |
| 0.239 | 0.083 | 0.483 | Hypoglycemic | 0.483 0.017 DBMET02847 | DBMET02847 | |
| 0.165 | 0.011 | 0.171 | Anabolic | 0.171 0.009 DBMET02847 | DBMET02847 | |
| 0.174 | 0.021 | 0.263 | Carbonic anhydrase III inhibitor | 0.263 0.008 DBMET02847 | DBMET02847 | |
| 0.162 | 0.01 | 0.162 | Acetylcholine M2 receptor antagonist | 0.057 0.047 DBMET02847 | ||
| 0.166 | 0.014 | 0.166 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.218 | 0.069 | 0.218 | Amyloid beta aggregation inhibitor | 0.211 0.072 DBMET02847 | ||
| 0.176 | 0.033 | 0.299 | Cholesterol synthesis inhibitor | 0.299 0.012 DBMET02847 | DBMET02847 | |
| 0.145 | 0.002 | 0.145 | Alpha 1d adrenoreceptor agonist | 0.064 0.009 DBMET02847 | ||
| 0.167 | 0.025 | 0.167 | Alpha 2c adrenoreceptor antagonist | |||
| 0.163 | 0.021 | 0.185 | Gastric antisecretory | 0.185 0.015 DBMET02847 | DBMET02847 | |
| 0.141 | 0.005 | 0.141 | Estrogen-related receptor beta agonist | 0.14 0.005 DBMET02847 | ||
| 0.184 | 0.05 | 0.403 | Amylase inhibitor | 0.403 0.009 DBMET02847 | DBMET02847 | |
| 0.155 | 0.022 | 0.265 | Creatine kinase inhibitor | 0.265 0.005 DBMET02847 | DBMET02847 | |
| 0.137 | 0.003 | 0.137 | Diamine oxidase inhibitor | 0.04 0.023 DBMET02847 | ||
| 0.235 | 0.102 | 0.302 | Immunostimulant | 0.302 0.078 DBMET02847 | DBMET02847 | |
| 0.152 | 0.022 | 0.154 | Urease inhibitor | 0.154 0.021 DBMET02847 | DBMET02847 | |
| 0.149 | 0.021 | 0.164 | Electron transport complex I inhibitor | 0.164 0.015 DBMET02847 | DBMET02847 | |
| 0.163 | 0.037 | 0.163 | Antibacterial (Helicobacter pylori) | 0.149 0.047 DBMET02847 | ||
| 0.157 | 0.032 | 0.157 | Vanilloid 1 agonist | 0.153 0.035 DBMET02847 | ||
| 0.281 | 0.157 | 0.281 | Analgesic | |||
| 0.129 | 0.005 | 0.196 | GABA B receptor agonist | 0.196 0.003 DBMET02847 | DBMET02847 | |
| 0.139 | 0.016 | 0.139 | Lanosterol 14 alpha demethylase inhibitor | 0.127 0.024 DBMET02847 | ||
| 0.161 | 0.039 | 0.25 | Cyclooxygenase 3 inhibitor | 0.25 0.009 DBMET02847 | DBMET02847 | |
| 0.145 | 0.027 | 0.145 | Transcription factor STAT6 inhibitor | 0.126 0.05 DBMET02847 | ||
| 0.179 | 0.062 | 0.252 | Phospholipase C inhibitor | 0.252 0.024 DBMET02847 | DBMET02847 | |
| 0.148 | 0.031 | 0.175 | Carbonic anhydrase XV inhibitor | 0.175 0.023 DBMET02847 | DBMET02847 | |
| 0.145 | 0.029 | 0.145 | Alpha 2 adrenoreceptor antagonist | |||
| 0.147 | 0.031 | 0.151 | GABA C receptor antagonist | 0.151 0.029 DBMET02847 | DBMET02847 | |
| 0.158 | 0.043 | 0.242 | Interleukin 4 antagonist | 0.242 0.014 DBMET02847 | DBMET02847 | |
| 0.145 | 0.031 | 0.145 | Mediator release inhibitor | 0.132 0.038 DBMET02847 | ||
| 0.143 | 0.028 | 0.293 | HIV-1 integrase (Overall Integration) inhibitor | 0.293 0.004 DBMET02847 | DBMET02847 | |
| 0.123 | 0.009 | 0.123 | NMDA 2A receptor antagonist | 0.099 0.013 DBMET02847 | ||
| 0.151 | 0.04 | 0.382 | Cystathionine beta-synthase inhibitor | 0.382 0.005 DBMET02847 | DBMET02847 | |
| 0.139 | 0.028 | 0.319 | NMDA receptor antagonist | 0.319 0.005 DBMET02847 | DBMET02847 | |
| 0.138 | 0.027 | 0.138 | GABA C receptor rho-1 antagonist | 0.136 0.029 DBMET02847 | ||
| 0.145 | 0.036 | 0.336 | GABA C receptor agonist | 0.336 0.007 DBMET02847 | DBMET02847 | |
| 0.133 | 0.026 | 0.133 | Alpha 2a adrenoreceptor antagonist | |||
| 0.118 | 0.011 | 0.118 | Maillard reaction inhibitor | 0.105 0.015 DBMET02847 | ||
| 0.135 | 0.029 | 0.162 | Prolactin inhibitor | 0.162 0.018 DBMET02847 | DBMET02847 | |
| 0.212 | 0.106 | 0.265 | DNA synthesis inhibitor | 0.265 0.058 DBMET02847 | DBMET02847 | |
| 0.16 | 0.056 | 0.16 | MAO inhibitor | 0.153 0.059 DBMET02847 | ||
| 0.107 | 0.004 | 0.107 | Alpha 1b adrenoreceptor agonist | |||
| 0.134 | 0.033 | 0.186 | Estrogen antagonist | 0.186 0.015 DBMET02847 | DBMET02847 | |
| 0.148 | 0.049 | 0.182 | Ca2+-transporting ATPase inhibitor | 0.182 0.006 DBMET02847 | DBMET02847 | |
| 0.1 | 0.003 | 0.1 | Beta 1 adrenoreceptor agonist | 0.036 0.006 DBMET02847 | ||
| 0.12 | 0.024 | 0.12 | NMDA 2 receptor antagonist | 0.118 0.024 DBMET02847 | ||
| 0.173 | 0.076 | 0.332 | Succinate dehydrogenase inhibitor | 0.332 0.007 DBMET02847 | DBMET02847 | |
| 0.118 | 0.022 | 0.118 | Histamine H2 receptor antagonist | |||
| 0.12 | 0.025 | 0.12 | Phosphodiesterase 6D inhibitor | 0.104 0.044 DBMET02847 | ||
| 0.119 | 0.026 | 0.139 | Ornithine decarboxylase inhibitor | 0.139 0.015 DBMET02847 | DBMET02847 | |
| 0.149 | 0.055 | 0.151 | Pregnane X receptor agonist | 0.151 0.05 DBMET02847 | DBMET02847 | |
| 0.116 | 0.025 | 0.116 | Somatostatin 1 agonist | 0.114 0.026 DBMET02847 | ||
| 0.138 | 0.047 | 0.138 | Papain-like protease (SARS coronavirus) inhibitor | 0.114 0.098 DBMET02847 | ||
| 0.144 | 0.057 | 0.211 | Toll-Like receptor 2 antagonist | 0.211 0.019 DBMET02847 | DBMET02847 | |
| 0.119 | 0.033 | 0.164 | Estrogen receptor beta antagonist | 0.164 0.013 DBMET02847 | DBMET02847 | |
| 0.162 | 0.076 | 0.187 | Neurotensin receptor agonist | 0.187 0.044 DBMET02847 | DBMET02847 | |
| 0.131 | 0.047 | 0.131 | MAO A inhibitor | |||
| 0.13 | 0.047 | 0.353 | Ferrochelatase inhibitor | 0.353 0.005 DBMET02847 | DBMET02847 | |
| 0.199 | 0.116 | 0.199 | DNA damaging | 0.167 0.148 DBMET02847 | ||
| 0.104 | 0.022 | 0.104 | Amidase inhibitor | 0.066 0.055 DBMET02847 | ||
| 0.132 | 0.049 | 0.154 | Microtubule formation inhibitor | 0.154 0.036 DBMET02847 | DBMET02847 | |
| 0.175 | 0.1 | 0.282 | Interleukin antagonist | 0.282 0.052 DBMET02847 | DBMET02847 | |
| 0.125 | 0.049 | 0.13 | Chelator | 0.13 0.045 DBMET02847 | DBMET02847 | |
| 0.078 | 0.003 | 0.078 | Beta 3 adrenoreceptor agonist | 0.016 0.005 DBMET02847 | ||
| 0.125 | 0.051 | 0.195 | Photosensitizer | 0.195 0.014 DBMET02847 | DBMET02847 | |
| 0.084 | 0.011 | 0.12 | NMDA receptor subunit 3A antagonist | 0.12 0.007 DBMET02847 | DBMET02847 | |
| 0.119 | 0.046 | 0.223 | DOPA decarboxylase inhibitor | 0.223 0.005 DBMET02847 | DBMET02847 | |
| 0.122 | 0.05 | 0.145 | Nav1.4 sodium channel blocker | 0.145 0.036 DBMET02847 | DBMET02847 | |
| 0.072 | 0.004 | 0.072 | Alpha 1a adrenoreceptor agonist | |||
| 0.08 | 0.011 | 0.08 | Stearoyl-CoA desaturase inhibitor | |||
| 0.079 | 0.011 | 0.096 | Alpha-mannosidase inhibitor | 0.096 0.007 DBMET02847 | DBMET02847 | |
| 0.091 | 0.023 | 0.091 | MAP kinase kinase 7 inhibitor | 0.087 0.029 DBMET02847 | ||
| 0.104 | 0.037 | 0.113 | Glutamate release inhibitor | 0.113 0.027 DBMET02847 | DBMET02847 | |
| 0.129 | 0.063 | 0.21 | Aldehyde dehydrogenase inhibitor | 0.21 0.025 DBMET02847 | DBMET02847 | |
| 0.147 | 0.081 | 0.249 | Interferon gamma antagonist | 0.249 0.029 DBMET02847 | DBMET02847 | |
| 0.206 | 0.14 | 0.28 | Gastrin inhibitor | 0.28 0.049 DBMET02847 | DBMET02847 | |
| 0.117 | 0.053 | 0.117 | Acetylcholine release stimulant | 0.11 0.066 DBMET02847 | ||
| 0.121 | 0.057 | 0.169 | TRPA1 agonist | 0.169 0.02 DBMET02847 | DBMET02847 | |
| 0.151 | 0.087 | 0.22 | Arachidonic acid antagonist | 0.22 0.017 DBMET02847 | DBMET02847 | |
| 0.095 | 0.034 | 0.326 | Histidine decarboxylase inhibitor | 0.326 0.005 DBMET02847 | DBMET02847 | |
| 0.1 | 0.039 | 0.1 | Acetylcholine nicotinic antagonist | |||
| 0.083 | 0.023 | 0.602 | Alcohol oxidase inhibitor | 0.602 0.003 DBMET02847 | DBMET02847 | |
| 0.098 | 0.038 | 0.098 | Myeloperoxidase inhibitor | |||
| 0.159 | 0.1 | 0.21 | Hepatoprotectant | 0.21 0.059 DBMET02847 | DBMET02847 | |
| 0.07 | 0.011 | 0.093 | Mannosidase inhibitor | 0.093 0.006 DBMET02847 | DBMET02847 | |
| 0.174 | 0.115 | 0.421 | Hypolipemic | 0.421 0.022 DBMET02847 | DBMET02847 | |
| 0.082 | 0.024 | 0.082 | Dopamine uptake inhibitor | |||
| 0.111 | 0.053 | 0.215 | Adenylate kinase inhibitor | 0.215 0.013 DBMET02847 | DBMET02847 | |
| 0.081 | 0.023 | 0.081 | Protein kinase C eta inhibitor | |||
| 0.092 | 0.035 | 0.16 | Glutamate dehydrogenase inhibitor | 0.16 0.014 DBMET02847 | DBMET02847 | |
| 0.139 | 0.083 | 0.139 | Hemostatic | |||
| 0.159 | 0.104 | 0.159 | P-glycoprotein inhibitor | 0.151 0.116 DBMET02847 | ||
| 0.106 | 0.051 | 0.106 | Nitric-oxide synthase inhibitor | |||
| 0.107 | 0.053 | 0.202 | UDP-glucose 4-epimerase inhibitor | 0.202 0.018 DBMET02847 | DBMET02847 | |
| 0.07 | 0.016 | 0.096 | NMDA receptor subunit 3B antagonist | 0.096 0.011 DBMET02847 | DBMET02847 | |
| 0.081 | 0.028 | 0.1 | NMDA receptor agonist | 0.1 0.019 DBMET02847 | DBMET02847 | |
| 0.063 | 0.01 | 0.079 | Dopamine D5 agonist | 0.079 0.006 DBMET02847 | DBMET02847 | |
| 0.098 | 0.046 | 0.183 | NADH dehydrogenase inhibitor | 0.183 0.012 DBMET02847 | DBMET02847 | |
| 0.078 | 0.027 | 0.114 | NMDA 2C receptor antagonist | 0.114 0.012 DBMET02847 | DBMET02847 | |
| 0.104 | 0.054 | 0.104 | Alpha adrenoreceptor antagonist | |||
| 0.08 | 0.03 | 0.08 | Protein kinase C beta inhibitor | |||
| 0.054 | 0.005 | 0.054 | Ceramide glucosyltransferase inhibitor | 0.046 0.01 DBMET02847 | ||
| 0.189 | 0.14 | 0.198 | Neuropeptide Y2 antagonist | 0.198 0.123 DBMET02847 | DBMET02847 | |
| 0.099 | 0.049 | 0.297 | Triose-phosphate isomerase inhibitor | 0.297 0.005 DBMET02847 | DBMET02847 | |
| 0.081 | 0.033 | 0.081 | Phospholipase D inhibitor | 0.068 0.059 DBMET02847 | ||
| 0.061 | 0.014 | 0.061 | Dopamine beta hydroxylase inhibitor | 0.056 0.019 DBMET02847 | ||
| 0.066 | 0.018 | 0.066 | Topoisomerase II beta inhibitor | 0.065 0.019 DBMET02847 | ||
| 0.066 | 0.019 | 0.066 | Potassium channel (Inward rectifier) blocker | |||
| 0.092 | 0.045 | 0.092 | Inducible nitric-oxide synthase inhibitor | |||
| 0.12 | 0.073 | 0.12 | DNA repair enzyme inhibitor | 0.119 0.073 DBMET02847 | ||
| 0.09 | 0.044 | 0.122 | D-Ala-D-Ala ligase inhibitor | 0.122 0.013 DBMET02847 | DBMET02847 | |
| 0.229 | 0.183 | 0.229 | 15-Lipoxygenase inhibitor | 0.215 0.197 DBMET02847 | ||
| 0.049 | 0.004 | 0.049 | Estrogen-related receptor gamma antagonist | 0.035 0.009 DBMET02847 | ||
| 0.145 | 0.1 | 0.22 | Nitric oxide antagonist | 0.22 0.061 DBMET02847 | DBMET02847 | |
| 0.091 | 0.046 | 0.179 | Carbonic anhydrase VI inhibitor | 0.179 0.016 DBMET02847 | DBMET02847 | |
| 0.136 | 0.092 | 0.156 | Heat shock protein 70 antagonist | 0.156 0.034 DBMET02847 | DBMET02847 | |
| 0.061 | 0.02 | 0.061 | Squalene epoxidase inhibitor | 0.047 0.041 DBMET02847 | ||
| 0.127 | 0.086 | 0.127 | Nav1.6 sodium channel blocker | |||
| 0.139 | 0.098 | 0.153 | CF transmembrane conductance regulator agonist | 0.153 0.071 DBMET02847 | DBMET02847 | |
| 0.083 | 0.043 | 0.139 | GABA aminotransferase inhibitor | 0.139 0.01 DBMET02847 | DBMET02847 | |
| 0.081 | 0.041 | 0.132 | Aminopeptidase I inhibitor | 0.132 0.016 DBMET02847 | DBMET02847 | |
| 0.087 | 0.048 | 0.087 | Opioid kappa receptor antagonist | |||
| 0.093 | 0.054 | 0.093 | Opioid antagonist | |||
| 0.088 | 0.051 | 0.175 | Vanilloid agonist | 0.175 0.008 DBMET02847 | DBMET02847 | |
| 0.101 | 0.064 | 0.174 | Aminopeptidase B inhibitor | 0.174 0.028 DBMET02847 | DBMET02847 | |
| 0.124 | 0.088 | 0.124 | Neurotrophic factor | 0.124 0.088 DBMET02847 | ||
| 0.083 | 0.047 | 0.102 | Na+ K+ transporting ATPase inhibitor | 0.102 0.03 DBMET02847 | DBMET02847 | |
| 0.041 | 0.005 | 0.041 | Calcium-sensing receptor antagonist | 0.015 0.011 DBMET02847 | ||
| 0.249 | 0.215 | 0.344 | Apoptosis agonist | 0.344 0.142 DBMET02847 | DBMET02847 | |
| 0.08 | 0.046 | 0.08 | Alpha 1b adrenoreceptor antagonist | |||
| 0.05 | 0.021 | 0.05 | Histamine H2 receptor agonist | |||
| 0.088 | 0.058 | 0.136 | Interleukin 5 antagonist | 0.136 0.015 DBMET02847 | DBMET02847 | |
| 0.079 | 0.05 | 0.214 | Keratolytic | 0.214 0.007 DBMET02847 | DBMET02847 | |
| 0.033 | 0.004 | 0.033 | Alpha 2c adrenoreceptor agonist | |||
| 0.032 | 0.004 | 0.032 | Estrogen-related receptor gamma agonist | 0.021 0.009 DBMET02847 | ||
| 0.055 | 0.028 | 0.055 | Dopamine transporter inhibitor | |||
| 0.034 | 0.008 | 0.036 | 1,3-Beta-glucan synthase inhibitor | 0.036 0.005 DBMET02847 | DBMET02847 | |
| 0.121 | 0.095 | 0.143 | Sphingosine 1-phosphate receptor 2 antagonist | 0.143 0.051 DBMET02847 | DBMET02847 | |
| 0.086 | 0.06 | 0.086 | Histamine N-methyltransferase inhibitor | |||
| 0.211 | 0.186 | 0.382 | Immunosuppressant | 0.382 0.071 DBMET02847 | DBMET02847 | |
| 0.079 | 0.054 | 0.08 | Interferon agonist | 0.08 0.052 DBMET02847 | DBMET02847 | |
| 0.055 | 0.031 | 0.125 | Factor IXa inhibitor | 0.125 0.005 DBMET02847 | DBMET02847 | |
| 0.063 | 0.039 | 0.139 | Purinergic P2X1 antagonist | 0.139 0.008 DBMET02847 | DBMET02847 | |
| 0.065 | 0.042 | 0.097 | Neuraminidase (influenza) inhibitor | 0.097 0.017 DBMET02847 | DBMET02847 | |
| 0.045 | 0.022 | 0.06 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.06 0.008 DBMET02847 | DBMET02847 | |
| 0.065 | 0.042 | 0.065 | 5 Hydroxytryptamine 2A agonist | |||
| 0.056 | 0.034 | 0.114 | Leukotriene B4 antagonist | 0.114 0.008 DBMET02847 | DBMET02847 | |
| 0.182 | 0.16 | 0.272 | Lipoxygenase inhibitor | 0.272 0.085 DBMET02847 | DBMET02847 | |
| 0.113 | 0.092 | 0.113 | Nav1.2 sodium channel blocker | |||
| 0.049 | 0.028 | 0.049 | Oleamide hydrolase inhibitor | |||
| 0.056 | 0.035 | 0.056 | Immunoglobulin Fc receptor antagonist | |||
| 0.067 | 0.046 | 0.067 | Dopamine agonist | |||
| 0.04 | 0.019 | 0.042 | Phosphoglycerate kinase inhibitor | 0.042 0.018 DBMET02847 | DBMET02847 | |
| 0.026 | 0.006 | 0.035 | Ileal bile acid transport inhibitor | 0.035 0.004 DBMET02847 | DBMET02847 | |
| 0.06 | 0.04 | 0.06 | Alpha 1d adrenoreceptor antagonist | |||
| 0.04 | 0.021 | 0.081 | Estrogen receptor alpha agonist | 0.081 0.012 DBMET02847 | DBMET02847 | |
| 0.091 | 0.072 | 0.126 | Bile acid receptor antagonist | 0.126 0.015 DBMET02847 | DBMET02847 | |
| 0.04 | 0.021 | 0.06 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.06 0.011 DBMET02847 | DBMET02847 | |
| 0.073 | 0.057 | 0.073 | Analgesic, opioid | |||
| 0.054 | 0.038 | 0.088 | Acyl-CoA dehydrogenase inhibitor | 0.088 0.019 DBMET02847 | DBMET02847 | |
| 0.074 | 0.058 | 0.096 | Estrogen receptor alpha antagonist | 0.096 0.03 DBMET02847 | DBMET02847 | |
| 0.028 | 0.012 | 0.029 | Vanilloid 2 agonist | 0.029 0.011 DBMET02847 | DBMET02847 | |
| 0.051 | 0.035 | 0.103 | Estrogen agonist | 0.103 0.017 DBMET02847 | DBMET02847 | |
| 0.044 | 0.028 | 0.044 | Oxytocin agonist | |||
| 0.122 | 0.107 | 0.177 | Insulin secretagoues | 0.177 0.051 DBMET02847 | DBMET02847 | |
| 0.063 | 0.048 | 0.065 | Interferon inducer | 0.065 0.043 DBMET02847 | DBMET02847 | |
| 0.04 | 0.025 | 0.04 | CF transmembrane conductance regulator antagonist | 0.04 0.026 DBMET02847 | ||
| 0.031 | 0.016 | 0.031 | Purinergic P2Y15 antagonist | |||
| 0.104 | 0.089 | 0.104 | Interleukin 8 antagonist | 0.101 0.094 DBMET02847 | ||
| 0.034 | 0.02 | 0.036 | Estrogen-related receptor beta antagonist | 0.036 0.016 DBMET02847 | DBMET02847 | |
| 0.124 | 0.11 | 0.233 | Phospholipase A2 inhibitor | 0.233 0.028 DBMET02847 | DBMET02847 | |
| 0.119 | 0.105 | 0.18 | Farnesoid X receptor antagonist | 0.18 0.029 DBMET02847 | DBMET02847 | |
| 0.183 | 0.17 | 0.259 | 12-Lipoxygenase inhibitor | 0.259 0.104 DBMET02847 | DBMET02847 | |
| 0.1 | 0.086 | 0.1 | Topoisomerase II inhibitor | |||
| 0.123 | 0.109 | 0.123 | MAP3K9 inhibitor | |||
| 0.044 | 0.031 | 0.044 | Dopamine D2 agonist | |||
| 0.068 | 0.058 | 0.281 | Porphobilinogen synthase inhibitor | 0.281 0.006 DBMET02847 | DBMET02847 | |
| 0.071 | 0.06 | 0.135 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.135 0.023 DBMET02847 | DBMET02847 | |
| 0.059 | 0.049 | 0.059 | Heme oxygenase stimulant | |||
| 0.09 | 0.08 | 0.09 | Nav1.1 sodium channel blocker | |||
| 0.108 | 0.099 | 0.164 | NADPH oxidase inhibitor | 0.164 0.047 DBMET02847 | DBMET02847 | |
| 0.082 | 0.073 | 0.123 | ATPase (Vacuolar H+) inhibitor | 0.123 0.018 DBMET02847 | DBMET02847 | |
| 0.098 | 0.089 | 0.098 | Nav1.5 sodium channel blocker | |||
| 0.06 | 0.051 | 0.132 | Leukotriene antagonist | 0.132 0.013 DBMET02847 | DBMET02847 | |
| 0.02 | 0.011 | 0.02 | Alpha 2b adrenoreceptor agonist | |||
| 0.111 | 0.103 | 0.182 | Lipid peroxidase inhibitor | 0.182 0.049 DBMET02847 | DBMET02847 | |
| 0.043 | 0.035 | 0.072 | Phosphorylase inhibitor | 0.072 0.019 DBMET02847 | DBMET02847 | |
| 0.065 | 0.059 | 0.065 | Secretase beta inhibitor | |||
| 0.069 | 0.063 | 0.069 | Topoisomerase II alpha inhibitor | |||
| 0.027 | 0.022 | 0.043 | Liver X receptor beta antagonist | 0.043 0.011 DBMET02847 | DBMET02847 | |
| 0.019 | 0.014 | 0.023 | Antibiotic Anthracycline-like | 0.023 0.006 DBMET02847 | DBMET02847 | |
| 0.055 | 0.05 | 0.085 | Neuraminidase inhibitor | 0.085 0.022 DBMET02847 | DBMET02847 | |
| 0.064 | 0.06 | 0.21 | Catalase inhibitor | 0.21 0.013 DBMET02847 | DBMET02847 | |
| 0.051 | 0.047 | 0.051 | Epithelial sodium channel blocker | |||
| 0.041 | 0.038 | 0.052 | Heme oxygenase inhibitor | 0.052 0.011 DBMET02847 | DBMET02847 | |
| 0.016 | 0.013 | 0.016 | KiSS-1 receptor antagonist | |||
| 0.03 | 0.028 | 0.048 | Glutamate (mGluR3) agonist | 0.048 0.005 DBMET02847 | DBMET02847 | |
| 0.059 | 0.056 | 0.109 | Sphingosine 1-phosphate receptor 4 agonist | 0.109 0.021 DBMET02847 | DBMET02847 | |
| 0.054 | 0.051 | 0.054 | Opioid delta receptor antagonist | |||
| 0.05 | 0.047 | 0.05 | Sphingosine kinase 2 inhibitor | |||
| 0.02 | 0.018 | 0.022 | Neuraminidase (Influenza B) inhibitor | 0.022 0.012 DBMET02847 | DBMET02847 | |
| 0.094 | 0.093 | 0.16 | DNA polymerase I inhibitor | 0.16 0.044 DBMET02847 | DBMET02847 | |
| 0.045 | 0.045 | 0.078 | Lysophosphatidic acid 3 receptor antagonist | 0.078 0.01 DBMET02847 | DBMET02847 | |
| 0.069 | 0.069 | 0.152 | Macrophage migration inhibitory factor inhibitor | 0.152 0.014 DBMET02847 | DBMET02847 | |
| 0.036 | 0.035 | 0.061 | Estradiol 17 beta-dehydrogenase inhibitor | 0.061 0.019 DBMET02847 | DBMET02847 | |
| 0.029 | 0.03 | 0.041 | Catechol O-methyltransferase inhibitor | 0.041 0.013 DBMET02847 | DBMET02847 | |
| 0.047 | 0.048 | 0.083 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.083 0.015 DBMET02847 | DBMET02847 | |
| 0.057 | 0.059 | 0.183 | Phosphofructokinase-1 inhibitor | 0.183 0.013 DBMET02847 | DBMET02847 | |
| 0.063 | 0.065 | 0.15 | Carbonic anhydrase XIII inhibitor | 0.15 0.022 DBMET02847 | DBMET02847 | |
| 0.039 | 0.045 | 0.042 | Adenylate cyclase 1 inhibitor | 0.042 0.038 DBMET02847 | DBMET02847 | |
| 0.036 | 0.042 | 0.051 | Glutamate (mGluR group III) agonist | 0.051 0.023 DBMET02847 | DBMET02847 | |
| 0.018 | 0.024 | 0.031 | Lysophosphatidic acid 1 receptor antagonist | 0.031 0.006 DBMET02847 | DBMET02847 | |
| 0.045 | 0.052 | 0.049 | Factor III inhibitor | 0.049 0.038 DBMET02847 | DBMET02847 | |
| 0.049 | 0.058 | 0.069 | Androgen agonist | 0.069 0.031 DBMET02847 | DBMET02847 | |
| 0.02 | 0.029 | 0.029 | Lysophosphatidic acid receptor 1 agonist | 0.029 0.012 DBMET02847 | DBMET02847 | |
| 0.014 | 0.022 | 0.019 | Factor IX inhibitor | 0.019 0.013 DBMET02847 | DBMET02847 | |
| 0.019 | 0.029 | 0.103 | Estrogen receptor beta agonist | 0.103 0.011 DBMET02847 | DBMET02847 | |
| 0.05 | 0.06 | 0.092 | Selectin antagonist | 0.092 0.031 DBMET02847 | DBMET02847 | |
| 0.049 | 0.06 | 0.066 | Sphingosine 1-phosphate receptor 3 antagonist | 0.066 0.03 DBMET02847 | DBMET02847 | |
| 0.031 | 0.042 | 0.049 | Tryptophan 5 hydroxylase inhibitor | 0.049 0.005 DBMET02847 | DBMET02847 | |
| 0.044 | 0.056 | 0.048 | NMDA 2B receptor antagonist | 0.048 0.046 DBMET02847 | DBMET02847 | |
| 0.021 | 0.032 | 0.048 | Thyroid hormone agonist | 0.048 0.005 DBMET02847 | DBMET02847 | |
| 0.024 | 0.036 | 0.047 | Lysophosphatidic acid 2 receptor antagonist | 0.047 0.009 DBMET02847 | DBMET02847 | |
| 0.03 | 0.043 | 0.045 | Erythropoietin receptor agonist | 0.045 0.024 DBMET02847 | DBMET02847 | |
| 0.017 | 0.03 | 0.047 | Prostaglandin F2 alpha agonist | 0.047 0.004 DBMET02847 | DBMET02847 | |
| 0.05 | 0.063 | 0.075 | Pregnane X receptor antagonist | 0.075 0.009 DBMET02847 | DBMET02847 | |
| 0.033 | 0.048 | 0.056 | Glycine transporter 2 inhibitor | 0.056 0.027 DBMET02847 | DBMET02847 | |
| 0.039 | 0.054 | 0.09 | Glucose-6-phosphate isomerase inhibitor | 0.09 0.006 DBMET02847 | DBMET02847 | |
| 0.022 | 0.037 | 0.058 | Prostaglandin D2 agonist | 0.058 0.005 DBMET02847 | DBMET02847 | |
| 0.069 | 0.084 | 0.116 | Glutathione S-transferase inhibitor | 0.116 0.025 DBMET02847 | DBMET02847 | |
| 0.042 | 0.057 | 0.136 | Aconitate hydratase inhibitor | 0.136 0.005 DBMET02847 | DBMET02847 | |
| 0.073 | 0.089 | 0.079 | Transcription factor NF kappa B stimulant | 0.079 0.073 DBMET02847 | DBMET02847 | |
| 0.03 | 0.047 | 0.045 | Membrane dipeptidase inhibitor | 0.045 0.02 DBMET02847 | DBMET02847 | |
| 0.057 | 0.074 | 0.12 | Cathepsin G inhibitor | 0.12 0.027 DBMET02847 | DBMET02847 | |
| 0.012 | 0.03 | 0.016 | Vitamin D receptor agonist | 0.016 0.013 DBMET02847 | DBMET02847 | |
| 0.015 | 0.033 | 0.028 | Leukotriene B4 receptor 2 antagonist | 0.028 0.01 DBMET02847 | DBMET02847 | |
| 0.131 | 0.149 | 0.216 | Non-steroidal antiinflammatory agent | 0.216 0.059 DBMET02847 | DBMET02847 | |
| 0.045 | 0.064 | 0.129 | Carbamoyl phosphate synthetase inhibitor | 0.129 0.014 DBMET02847 | DBMET02847 | |
| 0.035 | 0.055 | 0.042 | Neuraminidase (Influenza A) inhibitor | 0.042 0.039 DBMET02847 | DBMET02847 | |
| 0.057 | 0.077 | 0.275 | HIV-1 integrase inhibitor | 0.275 0.004 DBMET02847 | DBMET02847 | |
| 0.035 | 0.055 | 0.05 | Ribonucleoside-diphosphate reductase inhibitor | 0.05 0.04 DBMET02847 | DBMET02847 | |
| 0.083 | 0.103 | 0.123 | Beta glucuronidase inhibitor | 0.123 0.043 DBMET02847 | DBMET02847 | |
| 0.038 | 0.058 | 0.074 | Carbonic anhydrase VB inhibitor | 0.074 0.025 DBMET02847 | DBMET02847 | |
| 0.004 | 0.025 | 0.013 | Thyroid hormone beta agonist | 0.013 0.004 DBMET02847 | DBMET02847 | |
| 0.035 | 0.056 | 0.05 | Ribonucleotide reductase inhibitor | 0.05 0.042 DBMET02847 | DBMET02847 | |
| 0.045 | 0.066 | 0.065 | Dihydroorotate oxidase inhibitor | 0.065 0.023 DBMET02847 | DBMET02847 | |
| 0.02 | 0.041 | 0.025 | Sodium/glucose cotransporter inhibitor | 0.025 0.019 DBMET02847 | DBMET02847 | |
| 0.019 | 0.04 | 0.027 | Sodium/glucose cotransporter 2 inhibitor | 0.027 0.017 DBMET02847 | DBMET02847 | |
| 0.005 | 0.027 | 0.023 | Thromboxane agonist | 0.023 0.004 DBMET02847 | DBMET02847 | |
| 0.021 | 0.045 | 0.031 | Calcitonin receptor agonist | 0.031 0.026 DBMET02847 | DBMET02847 | |
| 0.035 | 0.06 | 0.166 | Aldose reductase inhibitor | 0.166 0.009 DBMET02847 | DBMET02847 | |
| 0.011 | 0.037 | 0.058 | Prostaglandin EP2 agonist | 0.058 0.005 DBMET02847 | DBMET02847 | |
| 0.156 | 0.183 | 0.217 | RNA-directed DNA polymerase inhibitor | 0.217 0.078 DBMET02847 | DBMET02847 | |
| 0.006 | 0.033 | 0.012 | Lysophosphatidic acid receptor 3 agonist | 0.012 0.011 DBMET02847 | DBMET02847 | |
| 0.047 | 0.074 | 0.091 | Carbonic anhydrase V inhibitor | 0.091 0.03 DBMET02847 | DBMET02847 | |
| 0.045 | 0.073 | 0.068 | Sphingosine 1-phosphate receptor 1 antagonist | 0.068 0.02 DBMET02847 | DBMET02847 | |
| 0.02 | 0.048 | 0.028 | Liver X receptor alpha antagonist | 0.028 0.022 DBMET02847 | DBMET02847 | |
| 0.016 | 0.044 | 0.033 | Prostaglandin EP4 antagonist | 0.033 0.014 DBMET02847 | DBMET02847 | |
| 0.05 | 0.079 | 0.086 | Carbonic anhydrase VA inhibitor | 0.086 0.033 DBMET02847 | DBMET02847 | |
| 0.016 | 0.045 | 0.026 | Lysine carboxypeptidase inhibitor | 0.026 0.02 DBMET02847 | DBMET02847 | |
| 0.072 | 0.101 | 0.105 | Granulocyte macrophage colony stimulating factor agonist | 0.105 0.029 DBMET02847 | DBMET02847 | |
| 0.057 | 0.086 | 0.093 | Exportin-1 inhibitor | 0.093 0.013 DBMET02847 | DBMET02847 | |
| 0.014 | 0.044 | 0.046 | Leukotriene B4 receptor 1 antagonist | 0.046 0.009 DBMET02847 | DBMET02847 | |
| 0.028 | 0.059 | 0.088 | Liver X receptor alpha agonist | 0.088 0.006 DBMET02847 | DBMET02847 | |
| 0.031 | 0.062 | 0.045 | Potassium channel Kv1.3 blocker | 0.045 0.034 DBMET02847 | DBMET02847 | |
| 0.014 | 0.045 | 0.017 | Methylmalonyl-CoA mutase inhibitor | 0.017 0.015 DBMET02847 | DBMET02847 | |
| 0.04 | 0.073 | 0.081 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.081 0.02 DBMET02847 | DBMET02847 | |
| 0.014 | 0.047 | 0.041 | Uridine phosphorylase inhibitor | 0.041 0.012 DBMET02847 | DBMET02847 | |
| 0.046 | 0.08 | 0.079 | Prostaglandin F2 alpha antagonist | 0.079 0.024 DBMET02847 | DBMET02847 | |
| 0.114 | 0.148 | 0.232 | Angiogenesis stimulant | 0.232 0.078 DBMET02847 | DBMET02847 | |
| 0.028 | 0.063 | 0.039 | Sphingosine 1-phosphate receptor 1 agonist | 0.039 0.034 DBMET02847 | DBMET02847 | |
| 0.058 | 0.093 | 0.114 | Peroxisome proliferator-activated receptor gamma antagonist | 0.114 0.011 DBMET02847 | DBMET02847 | |
| 0.009 | 0.045 | 0.016 | Nicotinic acid receptor 1 antagonist | 0.016 0.014 DBMET02847 | DBMET02847 | |
| 0.036 | 0.072 | 0.116 | Argininosuccinate synthase inhibitor | 0.116 0.016 DBMET02847 | DBMET02847 | |
| 0.049 | 0.086 | 0.066 | Ryanodine receptor antagonist | 0.066 0.023 DBMET02847 | DBMET02847 | |
| 0.015 | 0.052 | 0.035 | Arginase inhibitor | 0.035 0.027 DBMET02847 | DBMET02847 | |
| 0.052 | 0.089 | 0.1 | Glutamate (mGluR7) antagonist | 0.1 0.011 DBMET02847 | DBMET02847 | |
| 0.073 | 0.111 | 0.104 | Interleukin 1 beta converting enzyme inhibitor | 0.104 0.053 DBMET02847 | DBMET02847 | |
| 0.031 | 0.071 | 0.056 | Kainate receptor agonist | 0.056 0.009 DBMET02847 | DBMET02847 | |
| 0.014 | 0.054 | 0.038 | Glucagon receptor antagonist | 0.038 0.015 DBMET02847 | DBMET02847 | |
| 0.045 | 0.086 | 0.064 | Adenine nucleotide translocase inhibitor | 0.064 0.022 DBMET02847 | DBMET02847 | |
| 0.01 | 0.052 | 0.017 | Telomerase stimulant | 0.017 0.013 DBMET02847 | DBMET02847 | |
| 0.004 | 0.047 | 0.068 | Prostaglandin EP4 agonist | 0.068 0.004 DBMET02847 | DBMET02847 | |
| 0.039 | 0.082 | 0.1 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.1 0.017 DBMET02847 | DBMET02847 | |
| 0.078 | 0.121 | 0.096 | Proteasome inhibitor | 0.096 0.093 DBMET02847 | DBMET02847 | |
| 0.073 | 0.117 | 0.162 | Xanthine oxidase inhibitor | 0.162 0.03 DBMET02847 | DBMET02847 | |
| 0.057 | 0.101 | 0.081 | Androgen antagonist | 0.081 0.064 DBMET02847 | DBMET02847 | |
| 0.162 | 0.207 | 0.177 | Transcription factor STAT inhibitor | 0.177 0.172 DBMET02847 | DBMET02847 | |
| 0.012 | 0.058 | 0.019 | Caspase 8 inhibitor | 0.019 0.015 DBMET02847 | DBMET02847 | |
| 0.028 | 0.074 | 0.064 | Ornithine carbamoyltransferase inhibitor | 0.064 0.029 DBMET02847 | DBMET02847 | |
| 0.015 | 0.062 | 0.09 | Prostaglandin agonist | 0.09 0.006 DBMET02847 | DBMET02847 | |
| 0.062 | 0.109 | 0.137 | 5-Lipoxygenase inhibitor | 0.137 0.043 DBMET02847 | DBMET02847 | |
| 0.061 | 0.108 | 0.087 | Sphingosine 1-phosphate receptor antagonist | 0.087 0.034 DBMET02847 | DBMET02847 | |
| 0.041 | 0.088 | 0.095 | HIV-1 integrase (3'-Processing) inhibitor | 0.095 0.028 DBMET02847 | DBMET02847 | |
| 0.04 | 0.088 | 0.053 | Botulinum neurotoxin type A inhibitor | 0.053 0.05 DBMET02847 | DBMET02847 | |
| 0.004 | 0.052 | 0.016 | Glutamate (mGluR6) agonist | 0.016 0.005 DBMET02847 | DBMET02847 | |
| 0.009 | 0.057 | 0.06 | Prostaglandin E2 agonist | 0.06 0.005 DBMET02847 | DBMET02847 | |
| 0.018 | 0.066 | 0.065 | Fumarate hydratase inhibitor | 0.065 0.009 DBMET02847 | DBMET02847 | |
| 0.009 | 0.058 | 0.013 | Integrin beta6 antagonist | 0.013 0.012 DBMET02847 | DBMET02847 | |
| 0.066 | 0.115 | 0.219 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.219 0.013 DBMET02847 | DBMET02847 | |
| 0.046 | 0.095 | 0.072 | Leukotriene C antagonist | 0.072 0.013 DBMET02847 | DBMET02847 | |
| 0.012 | 0.062 | 0.018 | Tryptophan hydroxylase 1 inhibitor | 0.018 0.01 DBMET02847 | DBMET02847 | |
| 0.026 | 0.077 | 0.057 | Glutamate (mGluR8) agonist | 0.057 0.008 DBMET02847 | DBMET02847 | |
| 0.036 | 0.087 | 0.135 | Biliverdin reductase inhibitor | 0.135 0.011 DBMET02847 | DBMET02847 | |
| 0.064 | 0.115 | 0.133 | Alcohol dehydrogenase inhibitor | 0.133 0.027 DBMET02847 | DBMET02847 | |
| 0.028 | 0.081 | 0.057 | Carbonic anhydrase XIV inhibitor | 0.057 0.027 DBMET02847 | DBMET02847 | |
| 0.031 | 0.084 | 0.137 | Prostaglandin EP2 antagonist | 0.137 0.011 DBMET02847 | DBMET02847 | |
| 0.17 | 0.223 | 0.209 | Caspase 3 stimulant | 0.209 0.157 DBMET02847 | DBMET02847 | |
| 0.018 | 0.072 | 0.057 | ATP citrate lysase inhibitor | 0.057 0.006 DBMET02847 | DBMET02847 | |
| 0.017 | 0.072 | 0.056 | Liver X receptor beta agonist | 0.056 0.009 DBMET02847 | DBMET02847 | |
| 0.051 | 0.108 | 0.102 | Glutamate (mGluR6) antagonist | 0.102 0.01 DBMET02847 | DBMET02847 | |
| 0.021 | 0.079 | 0.031 | Carboxypeptidase B inhibitor | 0.031 0.027 DBMET02847 | DBMET02847 | |
| 0.052 | 0.111 | 0.11 | Glycine receptor agonist | 0.11 0.016 DBMET02847 | DBMET02847 | |
| 0.014 | 0.079 | 0.038 | 5-Alpha-reductase inhibitor | 0.038 0.025 DBMET02847 | DBMET02847 | |
| 0.029 | 0.093 | 0.048 | Leukotriene C4 antagonist | 0.048 0.012 DBMET02847 | DBMET02847 | |
| 0.068 | 0.133 | 0.112 | Electrolyte absorption antagonist | 0.112 0.043 DBMET02847 | DBMET02847 | |
| 0.007 | 0.074 | 0.017 | Thromboxane A2 agonist | 0.017 0.009 DBMET02847 | DBMET02847 | |
| 0.168 | 0.235 | 0.306 | Apoptosis antagonist | 0.306 0.082 DBMET02847 | DBMET02847 | |
| 0.026 | 0.094 | 0.042 | AICAR transformylase inhibitor | 0.042 0.033 DBMET02847 | DBMET02847 | |
| 0.072 | 0.143 | 0.135 | Toll-Like receptor 4 antagonist | 0.135 0.031 DBMET02847 | DBMET02847 | |
| 0.013 | 0.084 | 0.023 | Retinoic acid gamma receptor agonist | 0.023 0.013 DBMET02847 | DBMET02847 | |
| 0.039 | 0.112 | 0.083 | CDC25B inhibitor | 0.083 0.026 DBMET02847 | DBMET02847 | |
| 0.018 | 0.094 | 0.032 | Angiotensin II receptor antagonist | 0.032 0.028 DBMET02847 | DBMET02847 | |
| 0.035 | 0.113 | 0.055 | Thromboxane synthase inhibitor | 0.055 0.037 DBMET02847 | DBMET02847 | |
| 0.02 | 0.099 | 0.054 | Guanylate cyclase inhibitor | 0.054 0.018 DBMET02847 | DBMET02847 | |
| 0.079 | 0.159 | 0.112 | Cathepsin H inhibitor | 0.112 0.087 DBMET02847 | DBMET02847 | |
| 0.009 | 0.089 | 0.024 | Glutamate (mGluR1a) agonist | 0.024 0.013 DBMET02847 | DBMET02847 | |
| 0.015 | 0.095 | 0.032 | Retinoid X alpha receptor agonist | 0.032 0.027 DBMET02847 | DBMET02847 | |
| 0.092 | 0.172 | 0.187 | Mannose-6-phosphate isomerase inhibitor | 0.187 0.038 DBMET02847 | DBMET02847 | |
| 0.028 | 0.112 | 0.083 | HIV-1 integrase (Strand Transfer) inhibitor | 0.083 0.03 DBMET02847 | DBMET02847 | |
| 0.037 | 0.123 | 0.073 | DNA helicase inhibitor | 0.073 0.015 DBMET02847 | DBMET02847 | |
| 0.02 | 0.107 | 0.053 | Thromboxane A2 antagonist | 0.053 0.034 DBMET02847 | DBMET02847 | |
| 0.01 | 0.103 | 0.033 | Retinoid X receptor agonist | 0.033 0.027 DBMET02847 | DBMET02847 | |
| 0.092 | 0.188 | 0.162 | Growth hormone agonist | 0.162 0.078 DBMET02847 | DBMET02847 | |
| 0.09 | 0.188 | 0.259 | Pyruvate kinase inhibitor | 0.259 0.059 DBMET02847 | DBMET02847 | |
| 0.065 | 0.163 | 0.187 | T cell inhibitor | 0.187 0.008 DBMET02847 | DBMET02847 | |
| 0.005 | 0.103 | 0.015 | Prostacyclin agonist | 0.015 0.011 DBMET02847 | DBMET02847 | |
| 0.022 | 0.121 | 0.054 | Thromboxane antagonist | 0.054 0.037 DBMET02847 | DBMET02847 | |
| 0.017 | 0.117 | 0.041 | Angiotensin AT1 receptor antagonist | 0.041 0.031 DBMET02847 | DBMET02847 | |
| 0.033 | 0.134 | 0.053 | CD45 antagonist | 0.053 0.03 DBMET02847 | DBMET02847 | |
| 0.005 | 0.109 | 0.024 | Prostaglandin H2 antagonist | 0.024 0.019 DBMET02847 | DBMET02847 | |
| 0.024 | 0.13 | 0.063 | NMDA receptor glycine site agonist | 0.063 0.043 DBMET02847 | DBMET02847 | |
| 0.042 | 0.149 | 0.086 | CDC25A inhibitor | 0.086 0.037 DBMET02847 | DBMET02847 | |
| 0.062 | 0.169 | 0.094 | AMP-activated protein kinase stimulant | 0.094 0.078 DBMET02847 | DBMET02847 | |
| 0.041 | 0.153 | 0.055 | Lipocortins synthesis agonist | 0.055 0.05 DBMET02847 | DBMET02847 | |
| 0.029 | 0.141 | 0.049 | Glucose-6-phosphate translocase inhibitor | 0.049 0.04 DBMET02847 | DBMET02847 | |
| 0.003 | 0.116 | 0.047 | Peroxisome proliferator-activated receptor alpha antagonist | 0.047 0.009 DBMET02847 | DBMET02847 | |
| 0.007 | 0.122 | 0.015 | Thyroid hormone alpha agonist | 0.015 0.014 DBMET02847 | DBMET02847 | |
| 0.084 | 0.2 | 0.154 | Hexokinase inhibitor | 0.154 0.075 DBMET02847 | DBMET02847 | |
| 0.014 | 0.132 | 0.094 | Peroxisome proliferator-activated receptor alpha agonist | 0.094 0.014 DBMET02847 | DBMET02847 | |
| 0.061 | 0.183 | 0.213 | Bone formation stimulant | 0.213 0.032 DBMET02847 | DBMET02847 | |
| 0.017 | 0.142 | 0.064 | Xanthine dehydrogenase inhibitor | 0.064 0.035 DBMET02847 | DBMET02847 | |
| 0.017 | 0.15 | 0.051 | Liver X receptor agonist | 0.051 0.022 DBMET02847 | DBMET02847 | |
| 0.1 | 0.233 | 0.16 | Lipocortins synthesis antagonist | 0.16 0.092 DBMET02847 | DBMET02847 | |
| 0.015 | 0.149 | 0.049 | Glutamate (mGluR3) antagonist | 0.049 0.013 DBMET02847 | DBMET02847 | |
| 0.048 | 0.183 | 0.064 | MDM2 inhibitor | 0.064 0.059 DBMET02847 | DBMET02847 | |
| 0.083 | 0.218 | 0.177 | NOS3 expression enhancer | 0.177 0.051 DBMET02847 | DBMET02847 | |
| 0.056 | 0.203 | 0.126 | Caspase 3 inhibitor | 0.126 0.052 DBMET02847 | DBMET02847 | |
| 0.026 | 0.174 | 0.051 | Heparanase inhibitor | 0.051 0.041 DBMET02847 | DBMET02847 | |
| 0.016 | 0.167 | 0.036 | Retinoic acid alpha receptor agonist | 0.036 0.034 DBMET02847 | DBMET02847 | |
| 0.053 | 0.205 | 0.083 | ABCA1 expression enhancer | 0.083 0.08 DBMET02847 | DBMET02847 | |
| 0.025 | 0.178 | 0.077 | Leukotriene synthesis inhibitor | 0.077 0.039 DBMET02847 | DBMET02847 | |
| 0.085 | 0.243 | 0.155 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.155 0.137 DBMET02847 | DBMET02847 | |
| 0.053 | 0.215 | 0.102 | Thioredoxin reductase inhibitor | 0.102 0.027 DBMET02847 | DBMET02847 | |
| 0.024 | 0.188 | 0.043 | Glutamate (mGluR group III) antagonist | 0.043 0.033 DBMET02847 | DBMET02847 | |
| 0.006 | 0.172 | 0.029 | Kynurenine 3 monooxygenase inhibitor | 0.029 0.016 DBMET02847 | DBMET02847 | |
| 0.076 | 0.245 | 0.151 | DNA methyltransferase I inhibitor | 0.151 0.103 DBMET02847 | DBMET02847 | |
| 0.004 | 0.176 | 0.061 | Endothelin B receptor antagonist | 0.061 0.005 DBMET02847 | DBMET02847 | |
| 0.075 | 0.249 | 0.219 | Dual specificity phosphatase inhibitor | 0.219 0.046 DBMET02847 | DBMET02847 | |
| 0.005 | 0.18 | 0.106 | Endothelin receptor antagonist | 0.106 0.005 DBMET02847 | DBMET02847 | |
| 0.088 | 0.267 | 0.134 | Sphingosine 1-phosphate receptor 5 antagonist | 0.134 0.091 DBMET02847 | DBMET02847 | |
| 0.018 | 0.198 | 0.168 | Peroxisome proliferator-activated receptor gamma agonist | 0.168 0.009 DBMET02847 | DBMET02847 | |
| 0.007 | 0.187 | 0.057 | Urate transporter 1 inhibitor | 0.057 0.015 DBMET02847 | DBMET02847 | |
| 0.005 | 0.187 | 0.06 | Endothelin A receptor antagonist | 0.06 0.005 DBMET02847 | DBMET02847 | |
| 0.056 | 0.243 | 0.09 | Interleukin 12 antagonist | 0.09 0.073 DBMET02847 | DBMET02847 | |
| 0.007 | 0.202 | 0.034 | Prostacyclin antagonist | 0.034 0.022 DBMET02847 | DBMET02847 | |
| 0.077 | 0.277 | 0.251 | Platelet antagonist | 0.251 0.072 DBMET02847 | DBMET02847 | |
| 0.004 | 0.208 | 0.018 | Free fatty acid receptor 1 agonist | 0.018 0.012 DBMET02847 | DBMET02847 | |
| 0.006 | 0.211 | 0.037 | Free fatty acid receptor 1 antagonist | 0.037 0.019 DBMET02847 | DBMET02847 | |
| 0.072 | 0.279 | 0.143 | DNA methylase inhibitor | 0.143 0.123 DBMET02847 | DBMET02847 | |
| 0.028 | 0.241 | 0.151 | Protein-tyrosine phosphatase 1B inhibitor | 0.151 0.045 DBMET02847 | DBMET02847 | |
| 0.018 | 0.242 | 0.039 | Glutamate (mGluR8) antagonist | 0.039 0.018 DBMET02847 | DBMET02847 | |
| 0.034 | 0.292 | 0.151 | Uric acid excretion stimulant | 0.151 0.023 DBMET02847 | DBMET02847 | |
| 0.037 | 0.299 | 0.21 | Thrombolytic | 0.21 0.047 DBMET02847 | DBMET02847 | |
| 0.018 | 0.281 | 0.051 | Sphingosine 1-phosphate receptor 5 agonist | 0.051 0.044 DBMET02847 | DBMET02847 | |
| 0.061 | 0.326 | 0.173 | Platelet adhesion inhibitor | 0.173 0.086 DBMET02847 | DBMET02847 | |
| 0.036 | 0.321 | 0.199 | Protein-tyrosine phosphatase inhibitor | 0.199 0.047 DBMET02847 | DBMET02847 | |
| 0.085 | 0.387 | 0.141 | Catenin beta inhibitor | 0.141 0.128 DBMET02847 | DBMET02847 | |
| 0.021 | 0.359 | 0.125 | Glutamate receptor antagonist | 0.125 0.069 DBMET02847 | DBMET02847 | |
| 0.029 | 0.392 | 0.2 | Mcl-1 antagonist | 0.2 0.056 DBMET02847 | DBMET02847 | |
| 0.1 | 0.53 | 0.291 | Antiinflammatory | 0.291 0.224 DBMET02847 | DBMET02847 | |
| 0.022 | 0.497 | 0.122 | Cyclooxygenase inhibitor | 0.122 0.096 DBMET02847 | DBMET02847 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |